Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 18F-fluorocholine: a new oncologic PET tracer.

Literature DB >> 11752078

18F-fluorocholine: a new oncologic PET tracer.

T Hara¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2001 PMID： 11752078

Source DB: PubMed Journal: J Nucl Med ISSN： 0161-5505 Impact factor: 10.057

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Functional imaging of renal cell carcinoma.

Authors: Nathan Lawrentschuk; Ian D Davis; Damien M Bolton; Andrew M Scott
Journal: Nat Rev Urol Date: 2010-05 Impact factor: 14.432

2. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.

Authors: Jean-Noël Talbot; Fabrice Gutman; Laetitia Fartoux; Jean-Didier Grange; Nathalie Ganne; Khaldoun Kerrou; Dany Grahek; Françoise Montravers; Raoul Poupon; Olivier Rosmorduc
Journal: Eur J Nucl Med Mol Imaging Date: 2006-06-27 Impact factor: 9.236

Review 3. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.

Authors: Koen Mertens; Dominique Slaets; Bieke Lambert; Marjan Acou; Filip De Vos; Ingeborg Goethals
Journal: Eur J Nucl Med Mol Imaging Date: 2010-06-11 Impact factor: 9.236

4. ¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

Authors: Michael McCarthy; Teck Siew; Andrew Campbell; Nat Lenzo; Nigel Spry; Justin Vivian; Laurence Morandeau
Journal: Eur J Nucl Med Mol Imaging Date: 2010-09-23 Impact factor: 9.236

Review 10. State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.

Authors: Jolinta Lin; Seth Kligerman; Rakhi Goel; Payam Sajedi; Mohan Suntharalingam; Michael D Chuong
Journal: J Gastrointest Oncol Date: 2015-02

18F-fluorocholine: a new oncologic PET tracer.

Review 1. Functional imaging of renal cell carcinoma.

2. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.

Review 3. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature.

4. ¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

Review 5. The next generation of positron emission tomography radiopharmaceuticals in oncology.

Review 6. Radiosyntheses using fluorine-18: the art and science of late stage fluorination.

7. Reduced dimethylaminoethanol in [(18)F]fluoromethylcholine: an important step towards enhanced tumour visualization.

8. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.

Review 9. Fluorinated tracers for imaging cancer with positron emission tomography.

Review 10. State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.